PALM BEACH, Florida, November 10, 2016 /PRNewswire/ --
The popularity of telemedicine technology within the healthcare sector is booming, as tech companies are striving to develop the latest and innovative methods to improve and create new mobile applications and remote patient monitoring while implementing SAAS platforms to enhance the efficiency in various facets of operations. Market news updates covering Reliq Health Technologies Inc. (OTCQB: RQHTF) (TSX-V: RHT), Medidata Solutions, Inc. (NASDAQ: MDSO), HealthEquity, Inc. (NASDAQ: HQY), WebMD Health Corp. (NASDAQ: WBMD) and Cigna Corp. (NYSE: CI)
Reliq Health Technologies Inc. (OTCQB:RQHTF) (RHT.V), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that it has begun enrolling patients in the pilot of its remote patient monitoring and care collaboration solution with the NHS England. Read this full release and recent news releases for Reliq Health Technologies at http://marketnewsupdates.com/news/rqhtf.html
"We are very excited to be launching our pilot with the NHS England and enrolling patients at our pilot site, Imperial College Hospital, London, UK." said Dr. Lisa Crossley, CEO of Reliq Health. "The goal of this pilot is to demonstrate the value of Reliq Health's self-care solution in improving health outcomes and reducing the cost of care delivery for chronic disease patients after they are discharged home from hospital. Our platform uses a combination of secure cloud-based software, voice technology, wearables and sensors to support patients and their loved ones in proactively managing their chronic conditions at home, reducing exacerbations and disease-related complications, decreasing healthcare costs and enhancing patient and family satisfaction".
The NHS England is the largest single-payer healthcare system in the world, with an annual budget of over £100 Billion. There are over 15 million patients in England who are coping with at least one long-term health condition. These chronic conditions not only negatively impact patients' quality of life, but also account for over half of all General Practitioner (GP) appointments and 70% of hospital bed days. NHS England has estimated that improvements in self-care in this population could result in £584m in savings by 2021. Reliq's digital health solution creates a fully automated "virtual hospital ward" in the patient's home, providing real-time tracking of patients' vital signs, medication adherence, and movements within the home. The Reliq Health platform provides patients with audible alerts and reminders to collect their vitals, take their medications and perform prescribed rehab or fitness activities to support proactive self-care. Patient education materials are also provided through the Reliq Health platform to help patients and their families better understand and manage their chronic conditions.
In other sector related developments and announcements in markets this week:
Medidata Solutions, Inc. (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, recently announced that the Medidata Clinical Cloud® has been adopted by Nobelpharma to accelerate its efforts to deliver innovative treatments to patients with unmet medical needs. The Tokyo-based pharmaceutical company is using Medidata's cloud technology to power a clinical trial on sleep disorders in children with neurodevelopmental disabilities.
HealthEquity, Inc. (NASDAQ: HQY), announced last Friday that Matthew Sydney has resigned as Executive Vice President of Sales and Marketing of the Company to pursue a new leadership opportunity outside of HealthEquity. His resignation will be effective November 18, 2016. Steve Neeleman, Vice Chairman and founder of the Company, will provide executive oversight of the sales and marketing team while HealthEquity searches for a permanent replacement. HealthEquity is one of the nation's largest dedicated health savings custodians. The Company's innovative technology platform and tax-advantaged accounts help members build health savings, while controlling health care costs.
WebMD Health Corp. (NASDAQ: WBMD) announced that Steve Zatz, CEO, will participate in a fireside chat at the 2016 Wells Fargo Securities Technology, Media & Telecom Conference on Today, Thursday - November 10, 2016 at 9:20 a.m. ET. Investors, analysts and the general public are invited to listen to a live audio broadcast of the discussion over the Internet. The broadcast can be accessed at http://www.wbmd.com (in the Investor Relations section). A replay of the broadcast will be available at the same web address.
Cigna Corp. (NYSE: CI) Developments: A new Los Barrios Unidos clinic opened last Thursday in the South Oak Cliff section of Dallas and will provide help for local residents who suffer from persistent asthma through a program made possible by a Cigna Foundation grant. The $97,000 grant is part of the Cigna Foundation's focus on supporting non-profit organizations that are guiding at-risk individuals through the complex health care and social services systems.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated one thousand nine hundred dollars for news coverage of the current press release issued by Reliq Health Technologies Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.
Media Contact email: firstname.lastname@example.org- +1(561)325-8757